Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Operating Leases: 2022-2024

Historic Operating Leases for Sunshine Biopharma (SBFM) over the last 3 years, with Dec 2024 value amounting to $744,724.

  • Sunshine Biopharma's Operating Leases rose 44.61% to $636,708 in Q3 2025 from the same period last year, while for Sep 2025 it was $636,708, marking a year-over-year increase of 44.61%. This contributed to the annual value of $744,724 for FY2024, which is 38.16% up from last year.
  • Sunshine Biopharma's Operating Leases amounted to $744,724 in FY2024, which was up 38.16% from $539,035 recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Operating Leases peaked at $744,724 during FY2024, and registered a low of $539,035 during FY2023.
  • Over the past 3 years, Sunshine Biopharma's median Operating Leases value was $642,232 (recorded in 2022), while the average stood at $641,997.
  • In the last 5 years, Sunshine Biopharma's Operating Leases fell by 16.07% in 2023 and then spiked by 38.16% in 2024.
  • Yearly analysis of 3 years shows Sunshine Biopharma's Operating Leases stood at $642,232 in 2022, then declined by 16.07% to $539,035 in 2023, then surged by 38.16% to $744,724 in 2024.